Delivery Order 75F40119D10027-75F40119F19001
Award Date 9/23/19
Potential Completion Date 3/31/22
Potential Value $250K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92109, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $90,324.00 firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Nanion Technologies Inc., a small business vendor. The contract is for the provision of a Real Time Cell Analysis Cardio System to support the monitoring of drug-induced cardiotoxicity. The system will be used to perform advanced cellular research and drug discovery studies at the FDA's facilities in Silver Spring, Maryland. The contract was set aside for small business competition,...
- This $269,500 firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Anabios Corporation, a translational research company that provides human-based testing services. The contract is for the delivery of high-quality human dorsal root ganglia (hDRG) samples from four normal (non-pain) donors, to support NCATS' research projects related to the HEAL Initiative, which aims to accelerate solutions to the...
- <p>The National Heart Lung and Blood Institute awarded a purchase order to Anabios Corporation for $149,300 on August 15, 2016, for molecular roles of CDK5 in pain signaling research.</p> <p>Work is performed in San Diego, California. The order is firm fixed price with an ultimate completion date of August 14, 2019. No set-aside applies to this acquisition.</p>
- The Food and Drug Administration awarded a purchase order to 28Bio, Inc. for $143,020.98 to conduct central nervous system 3D brain organoid neuropharmacological analysis under Executive Order 14398, with an award date of August 1, 2026 and completion date of April 30, 2027. Performance takes place in Metairie, Louisiana. The work involves functional examination of neuromodulatory effects of a marketed small molecule drug using human CNS 3D brain organoids, including acute and chronic...
- The Department of Health and Human Services' Food and Drug Administration awarded a purchase order to Ionoptix LLC, a for-profit organization, for the procurement of a Calcium and Contractility System plus four years of preventative maintenance. The potential value of the contract is $147,020.00 and it has a completion date of February 29, 2028. The contract is a firm fixed-price contract with no set-aside designation. The original solicitation was a pre-solicitation notice for a sole source...
- <p>The U.S. Food and Drug Administration (FDA) awarded a $41,184.00 firm fixed price purchase order to Alomone Lab LTD, a for-profit organization located in Israel, for the procurement of reagents for electrophysiology studies. This sole source award, which has an ultimate completion date of April 29, 2025, was made by the FDA's Office of Acquisition and Grants Services. No set-aside designation was used for this contract.</p>
- <p>The Department of Health and Human Services Food and Drug Administration awarded a $262,382.30 delivery order against the Solutions for Enterprise Wide Procurement V government-wide acquisition contract to Anacapa Micro Products, Inc., doing business as Anacapa Micro Products Inc. The firm fixed price order is for encasement against NASA SEWP FDA cybersecurity data protections and will be performed in Rockville, Maryland between April 21, 2022 and April 30, 2023.</p>
- This is a $140,204.00 firm-fixed-price purchase order contract awarded by the U.S. Department of Health and Human Services' Food and Drug Administration (FDA) to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of goods. The contract is for the delivery of a Micro-Electrode Assay System, a specialized laboratory instrument used in biomedical research initiatives across agencies like the National Institutes of Health (NIH), EPA, and VA. As a small business set-aside, this award...
- The Food and Drug Administration (FDA) awarded a $346,227.62 firm-fixed-price purchase order contract to Nanion Technologies Inc., a for-profit scientific instrumentation company, for a 5-year service maintenance plan for a SyncroPatch 384 system. The contract will provide preventative maintenance, technical support, software upgrades, and repairs for the equipment at the FDA facility in Silver Spring, Maryland. This contract was competed without a set-aside designation. The primary products and...
- This federal contract award, valued at $25,233.29, was issued by the Food and Drug Administration (FDA) to Technical Communities, Inc., a small business vendor based in San Mateo, California. The contract is for the delivery of services related to "PREDICTIVE CLINICAL BIOMARKERS FOR DOXORUBICIN-INDUCED CARDIOTOXICITY." It was awarded on a firm fixed-price basis and is not associated with a set-aside program. The contract was issued as a Delivery Order under the General Services...
Teaming
Find teaming partners for this award
- 75F40119D10027Indefinite Delivery Contract
- 75F40119D10027-75F40119F19001Delivery Order
Anabios Corporation was awarded a firm fixed price delivery order against an unspecified contract vehicle to provide electrophysiological and contractility assessment services on primary adult ventricular tissues to the Food and Drug Administration (FDA). With a potential value of $249,707.50 and period of performance through March 31, 2022, the services will support the FDA's evaluation of drug effects on cardiac function. Testing will be conducted at Anabios's facility in San Diego, California with no set-aside designation applied to this $249,707.50 award.
Generated 1/2/24, 7:52 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Supplemental Agreement for work within scope | $0 | 11/15/21 | |
| P00003 | Change Order | $0 | 9/8/21 | |
| P00002 | Supplemental Agreement for work within scope | $0 | 2/23/21 | |
| P00001 | Supplemental Agreement for work within scope | $0 | 9/21/20 | |
| Not listed | Not listed | $249.7k | 9/23/19 |